This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Genotoxicity Remove Regulation Remove RNA Related Topics
Bioassay Genetic Engineering In-Vivo In-Vitro Hormones Gene Packaging Genomics Genome Containment More Related Topics >
article thumbnail

IN FOCUS: Solvias

Pharmaceutical Technology

DECEMBER 9, 2022

Our laboratories operate to the highest quality standards under international organisation for standardisation (ISO), good manufacturing practice (GMP), good laboratory practice (GLP) and US Food and Drug Administration (FDA) regulations. However, messenger RNA (mRNA) based vaccines present particular analytical challenges.

Development 130
Development Manufacturing Production Vaccination 130
article thumbnail

Accelerating NDA filing through faster carcinogenicity assessment

Drug Discovery World

MAY 10, 2023

This stage is more highly regulated and consists of both preclinical testing and clinical trials. Specific guidelines set forth to regulate these testing processes are issued by the ICH, a non-profit organisation with representation from global regulatory agencies and pharmaceutical companies.

Bioassay 52
Bioassay Genotoxicity Drugs In-Vivo 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024